Effects of photobiomodulation with low-level laser therapy in burning mouth syndrome: A randomized clinical trial
Loading...
Download
Official URL
Full text at PDC
Publication date
2020
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Citations
Exportar
Citation
de Pedro M, López-Pintor RM, Casañas E, Hernández G. Effects of photobiomodulation with low-level laser therapy in burning mouth syndrome: A randomized clinical trial. Oral Dis. 2020 Nov;26(8):1764-1776. doi: 10.1111/odi.13443. Epub 2020 Jun 24. PMID: 32460396.
Abstract
Antecedentes
La fotobiomodulación (PBM) ha demostrado ser efectiva en diferentes afecciones dolorosas.
Objetivos
Evaluar el efecto de la fotobiomodulación para el tratamiento del dolor en pacientes con síndrome de boca ardiente (SBA), además de analizar el impacto sobre diferentes aspectos de la calidad de vida.
Métodos
Se realizó un ensayo clínico aleatorizado, simple ciego, en 20 pacientes con SBA. Se aplicó fotobiomodulación en el grupo de estudio (n = 10) con una dosis de 12 J/cm2 durante 10 sesiones, comparando con un grupo placebo (n = 10) con el láser apagado. El dolor se evaluó mediante la escala analógica visual (EAV) antes de iniciar cada sesión de tratamiento, y en las citas de seguimiento a 1 y 4 meses. También se completaron algunos cuestionarios validados de salud general: SF-36, OHIP-14, Epworth, SCL 90-R y McGill.
Resultados
Todos los pacientes (n = 10) del grupo de estudio mejoraron su dolor al finalizar el tratamiento y permanecieron entre el 90% (n = 9) en el seguimiento a los 4 meses. Se encontró mejoría significativa en el grupo de estudio en algunos apartados del cuestionario McGill, escala de Epworth y SCL 90-R al finalizar el tratamiento y en los seguimientos de 1 y 4 meses.
Conclusiones
La fotobiomodulación parece ser eficaz en la reducción del dolor en pacientes con SBA, así como, tener un impacto positivo en el estado psicológico de estos pacientes.
Background: Photobiomodulation (PBM) has proven to be effective in different painful conditions. Objectives: To assess the effect of photobiomodulation for pain management in burning mouth syndrome (BMS) patients, besides analysing the impact on different aspects of quality of life. Methods: A randomized, single-blind, clinical trial was performed among 20 patients with BMS. Photobiomodulation was applied in the study group (n = 10) with a dose of 12 J/cm2 during 10 sessions, comparing with a placebo group (n = 10) with the laser turned off. Pain was assessed using the visual analogue scale (VAS) before starting each treatment session, and at the 1-month and 4-month follow-up appointments. Some validated questionnaires for general health were also complete: SF-36, OHIP-14, Epworth, SCL 90-R and McGill. Results: All patients (n = 10) in the study group improved their pain ending treatment and remaining among 90% (n = 9) in the 4-month follow-up. Significant improvement was found in the study group in some sections of McGill questionnaire, Epworth scale, and SCL 90-R at the end of the treatment and in the 1-month and 4-month follow-ups. Conclusions: Photobiomodulation seems to be effective in reducing pain in patients with BMS, as well as, having a positive impact on the psychological state of these patients. Keywords: Burning Mouth Syndrome; clinical trial; low-level laser therapy; pain; photobiomodulation; quality of life.
Background: Photobiomodulation (PBM) has proven to be effective in different painful conditions. Objectives: To assess the effect of photobiomodulation for pain management in burning mouth syndrome (BMS) patients, besides analysing the impact on different aspects of quality of life. Methods: A randomized, single-blind, clinical trial was performed among 20 patients with BMS. Photobiomodulation was applied in the study group (n = 10) with a dose of 12 J/cm2 during 10 sessions, comparing with a placebo group (n = 10) with the laser turned off. Pain was assessed using the visual analogue scale (VAS) before starting each treatment session, and at the 1-month and 4-month follow-up appointments. Some validated questionnaires for general health were also complete: SF-36, OHIP-14, Epworth, SCL 90-R and McGill. Results: All patients (n = 10) in the study group improved their pain ending treatment and remaining among 90% (n = 9) in the 4-month follow-up. Significant improvement was found in the study group in some sections of McGill questionnaire, Epworth scale, and SCL 90-R at the end of the treatment and in the 1-month and 4-month follow-ups. Conclusions: Photobiomodulation seems to be effective in reducing pain in patients with BMS, as well as, having a positive impact on the psychological state of these patients. Keywords: Burning Mouth Syndrome; clinical trial; low-level laser therapy; pain; photobiomodulation; quality of life.